DDIT3 and glioblastoma: As anticipated from previous studies, tubastatin treatment led to dose-dependent downregulation of HDAC6, robust upregulation of the stress gene DDIT3, and significantly reduced cell viability in all tested GBM cells (Figure 4A–C,G–I,M–O).